EG22630A - Process for preparation of pyrazoleo (4,3-D) pyrimidin-7-ones and intermediates thereof - Google Patents

Process for preparation of pyrazoleo (4,3-D) pyrimidin-7-ones and intermediates thereof

Info

Publication number
EG22630A
EG22630A EG126999A EG126999A EG22630A EG 22630 A EG22630 A EG 22630A EG 126999 A EG126999 A EG 126999A EG 126999 A EG126999 A EG 126999A EG 22630 A EG22630 A EG 22630A
Authority
EG
Egypt
Prior art keywords
pyrazoleo
pyrimidin
intermediates
ones
preparation
Prior art date
Application number
EG126999A
Other languages
English (en)
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10840421&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG22630(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Application granted granted Critical
Publication of EG22630A publication Critical patent/EG22630A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EG126999A 1998-10-12 1999-10-11 Process for preparation of pyrazoleo (4,3-D) pyrimidin-7-ones and intermediates thereof EG22630A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9822238.3A GB9822238D0 (en) 1998-10-12 1998-10-12 Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof

Publications (1)

Publication Number Publication Date
EG22630A true EG22630A (en) 2003-05-31

Family

ID=10840421

Family Applications (1)

Application Number Title Priority Date Filing Date
EG126999A EG22630A (en) 1998-10-12 1999-10-11 Process for preparation of pyrazoleo (4,3-D) pyrimidin-7-ones and intermediates thereof

Country Status (48)

Country Link
US (3) US6207829B1 (fr)
EP (1) EP0994115B1 (fr)
JP (1) JP3721021B2 (fr)
KR (1) KR100380954B1 (fr)
CN (2) CN1207295C (fr)
AP (1) AP1233A (fr)
AR (1) AR019244A1 (fr)
AT (1) ATE290003T1 (fr)
AU (1) AU756463B2 (fr)
BG (1) BG63205B1 (fr)
BR (1) BR9905092A (fr)
CA (1) CA2285733C (fr)
CO (1) CO5150214A1 (fr)
CR (1) CR6118A (fr)
CU (1) CU22928A3 (fr)
CZ (1) CZ296816B6 (fr)
DE (1) DE69923906T2 (fr)
DK (1) DK0994115T3 (fr)
DZ (1) DZ2912A1 (fr)
EA (1) EA003774B1 (fr)
EE (1) EE04192B1 (fr)
EG (1) EG22630A (fr)
ES (1) ES2237049T3 (fr)
GB (1) GB9822238D0 (fr)
GE (1) GEP20022700B (fr)
GT (1) GT199900172A (fr)
HR (1) HRP990318B1 (fr)
HU (1) HU226162B1 (fr)
ID (1) ID23351A (fr)
IL (11) IL152928A (fr)
IS (1) IS1951B (fr)
MA (1) MA25007A1 (fr)
MY (1) MY124620A (fr)
NO (1) NO313700B1 (fr)
OA (1) OA11165A (fr)
PE (1) PE20001086A1 (fr)
PL (1) PL198150B1 (fr)
PT (1) PT994115E (fr)
RS (1) RS49762B (fr)
SG (1) SG118060A1 (fr)
SI (1) SI0994115T1 (fr)
SK (1) SK285215B6 (fr)
TN (1) TNSN99189A1 (fr)
TR (1) TR199902541A2 (fr)
TW (1) TW589314B (fr)
UA (1) UA66787C2 (fr)
UY (1) UY25750A1 (fr)
ZA (1) ZA996412B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078760A1 (fr) * 1999-06-21 2000-12-28 The Biochemical Pharmaceutical Factory Of Zhuhai Sez Procede de preparation de sildenafil, agent et procede d'obtention d'un comprime mixte a base de sildenafil et de chlorhydrate d'apomorphine
US6667398B2 (en) 2000-06-22 2003-12-23 Pfizer Inc Process for the preparation of pyrazolopyrimidinones
YU93902A (sh) * 2000-06-22 2005-11-28 Pfizer Products Inc. Postupak za pripremanje pirazolopirimidinona
EP1176142A1 (fr) * 2000-07-28 2002-01-30 Pfizer Inc. Procédé pour la préparation de pyrazoles
US6407259B1 (en) 2000-07-28 2002-06-18 Pfizer Inc. Process for the preparation of pyrazoles
YU51701A (sh) * 2000-07-28 2003-12-31 Pfizer Inc. Postupak za dobijanje jedinjenja pirazola/4,3-d/ pirimidin-7-ona i njihovih derivata
PE20020394A1 (es) 2000-08-18 2002-06-21 Agouron Pharma Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
AU2002358772B2 (en) 2001-12-20 2008-11-20 Merck Serono Sa Pyrrolidine derivatives as prostaglandin modulators
CA2470427C (fr) * 2001-12-21 2012-07-10 Cytokinetics, Incorporated Compositions et methodes permettant de traiter l'insuffisance cardiaque
SI1509525T1 (sl) 2002-05-31 2006-12-31 Schering Corp Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev
WO2004072079A1 (fr) * 2003-02-11 2004-08-26 Pfizer Limited Compose d'hemi-citrate de sildenafil hydrate et anhydre
WO2004086865A1 (fr) * 2003-03-27 2004-10-14 Cytokinetics, Inc. Composes, compositions et methodes
CN100360531C (zh) * 2003-12-18 2008-01-09 中国人民解放军军事医学科学院放射与辐射医学研究所 用于预防或治疗阳萎和性冷淡的新吡唑并嘧啶类化合物
US20070010525A1 (en) * 2005-06-27 2007-01-11 Meyer Jackson Method and compositions for modulating neuropeptide hormone secretion
NL2000291C2 (nl) * 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
EP2024369A4 (fr) * 2006-06-05 2010-10-27 Matrix Lab Ltd Nouveau procédé de préparation du citrate de sildénafil
CZ308056B6 (cs) * 2015-07-20 2019-11-27 Ustav Experimentalni Botaniky Av Cr V V I 5-Substituované-7-[4-(substituované)benzyl]amino-3-isopropylpyrazolo[4,3-d]pyrimidiny, jejich použití jako antirevmatika, a farmaceutické přípravky
WO2017168174A1 (fr) 2016-04-02 2017-10-05 N4 Pharma Uk Limited Nouvelles formes pharmaceutiques du sildénafil
CN107759603B (zh) * 2016-08-18 2020-09-01 四川科伦药物研究院有限公司 一种杂环化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992441A (en) * 1972-12-26 1976-11-16 Pfizer Inc. Sulfamylbenzoic acids
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
CA2288910C (fr) * 1997-04-25 2003-06-24 Pfizer Inc. Pyrazolopyrimidinones pour des dysfonctions sexuelles

Also Published As

Publication number Publication date
CZ353299A3 (cs) 2000-05-17
TR199902541A2 (xx) 2000-07-21
DZ2912A1 (fr) 2004-03-01
IL152924A (en) 2004-02-19
DK0994115T3 (da) 2005-06-20
IL152928A (en) 2007-07-04
KR100380954B1 (ko) 2003-04-21
HRP990318B1 (en) 2004-06-30
IL152926A0 (en) 2003-06-24
EP0994115A3 (fr) 2000-05-24
NO994943D0 (no) 1999-10-11
BG103794A (en) 2000-09-29
MA25007A1 (fr) 2000-07-01
AP9901672A0 (en) 1999-12-31
CO5150214A1 (es) 2002-04-29
US20030069422A1 (en) 2003-04-10
AR019244A1 (es) 2001-12-26
NO994943L (no) 2000-04-13
CU22928A3 (es) 2004-02-20
US20010009962A1 (en) 2001-07-26
IL152927A (en) 2004-06-01
ES2237049T3 (es) 2005-07-16
BG63205B1 (bg) 2001-06-29
AU5358199A (en) 2000-04-13
MY124620A (en) 2006-06-30
AP1233A (en) 2003-12-18
CZ296816B6 (cs) 2006-06-14
CA2285733A1 (fr) 2000-04-12
PE20001086A1 (es) 2000-10-18
TW589314B (en) 2004-06-01
CA2285733C (fr) 2004-08-24
TNSN99189A1 (fr) 2005-11-10
US6207829B1 (en) 2001-03-27
EA003774B1 (ru) 2003-08-28
IL152928A0 (en) 2003-06-24
JP2000119273A (ja) 2000-04-25
GT199900172A (es) 2001-03-28
IL152924A0 (en) 2003-06-24
PL198150B1 (pl) 2008-05-30
EP0994115B1 (fr) 2005-03-02
UA66787C2 (en) 2004-06-15
IL152927A0 (en) 2003-06-24
HK1027559A1 (en) 2001-01-19
KR20000028987A (ko) 2000-05-25
CR6118A (es) 2005-09-16
HUP9903469A3 (en) 2000-10-30
DE69923906D1 (de) 2005-04-07
BR9905092A (pt) 2000-08-08
ID23351A (id) 2000-04-13
EA199900822A3 (ru) 2000-08-28
EP0994115A2 (fr) 2000-04-19
IS1951B (is) 2004-10-13
IL132273A (en) 2004-06-20
IL152926A (en) 2004-02-19
CN1473831A (zh) 2004-02-11
AU756463B2 (en) 2003-01-16
HUP9903469A2 (hu) 2000-08-28
DE69923906T2 (de) 2006-04-06
HU9903469D0 (en) 1999-12-28
HU226162B1 (en) 2008-05-28
CN1255497A (zh) 2000-06-07
EE04192B1 (et) 2003-12-15
ZA996412B (en) 2001-04-11
GB9822238D0 (en) 1998-12-09
IL152923A0 (en) 2003-06-24
ATE290003T1 (de) 2005-03-15
IS5209A (is) 2000-04-13
HRP990318A2 (en) 2000-06-30
IL152923A (en) 2004-02-08
SI0994115T1 (fr) 2005-08-31
PL335959A1 (en) 2000-04-25
JP3721021B2 (ja) 2005-11-30
GEP20022700B (en) 2002-05-27
UY25750A1 (es) 2001-08-27
PT994115E (pt) 2005-06-30
OA11165A (en) 2003-04-22
EE9900507A (et) 2000-06-15
IL132273A0 (en) 2001-03-19
EA199900822A2 (ru) 2000-04-24
SG118060A1 (en) 2006-01-27
SK138599A3 (en) 2000-05-16
CN1207295C (zh) 2005-06-22
SK285215B6 (sk) 2006-09-07
NO313700B1 (no) 2002-11-18
RS49762B (sr) 2008-04-04
YU48999A (sh) 2002-06-19

Similar Documents

Publication Publication Date Title
AP9901672A0 (en) Process for preparation of pyrazolo (4,3-d)pyrimidin-7- ones and intermediates thereof
AU8758298A (en) Process for the preparation of 2'-fluoro-5-methyl-beta -l-arabinofuranosyluridine
HUP9901176A3 (en) Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives and their intermediates
HUP0100640A3 (en) Process for the preparation of 1,4-dihydropyridines
IL133140A0 (en) Novel process for the preparation of 4-aryl-piperidines
EP0692476A3 (fr) Procédé amélioré pour la préparation de N,N'-carbonyldiazoles, spécialement de N,N'-carbonyldiimidazole
ZA963019B (en) Process for the preparation of 1,1-difluoroethane
HUP0003452A3 (en) Process for the preparation of 1-aryl-3-cyclopropyl-1,3-propanediones
ZA987741B (en) Process for the preparation of oxazaphosphorine-2-amines
HUP0001757A3 (en) Improved process for the preparation of halo-4-phenoxyquinolines
ZA988397B (en) Process for the preparation of substituted 5,6-dihydro-2H-pyran-2-ones
IL118731A (en) Process for the preparation of 2,2-dialkyl-arylidenecycloalkanones
IL135553A0 (en) Process for the preparation of azacycloalkyalkanoyl pseudotetrapeptides
HUP0102297A3 (en) Process for preparation of 4,5-epoxymorphinan-6-oxi-glucuronides
HUP9902745A3 (en) Process for the preparation of benzylcarbazate
ZA965515B (en) Process for the preparation of 3-hydroxyoxetanes
GB9807032D0 (en) Process for the preparation of (S)-3-carbethoxy-3-benzylpiperidine
IL120556A (en) Process for the preparation of 3,3,5-trichloroglutarimide
IL132237A (en) Process for the preparation of 3-isochromanone
ZA981924B (en) Process for the preparation of n-carboxylalkyl-3-fluoro-4- dialkylaminoanilines
MD956F1 (en) N-carboxyaryl-N',N'-dimethylthiouûreas preparation process
IL139521A0 (en) Process for preparation of 4,5-epoxymorphinan-6-oxyglucuronides
SG63715A1 (en) Process for the preparation of 2, 3-pyridinedicarboximides
IL119112A0 (en) Process for the preparation of 4,6-dichloropyrimidines
AU5222298A (en) Process for the preparation of 1,8-naphthosultam